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a b s t r a c t
The rapid synthesis of cis-2,6-disubstituted dihydropyrans is achieved in a three-component, one-pot
cascade reaction. BiBr3-mediated addition of ketene silyl acetals or silyl enol ethers to b,g-unsaturated cis-
4-trimethylsilyl-3-butenal provides aMukaiyama aldol adduct containing a vinylsilanemoiety tethered to
a silyl ether. Addition of a second aldehyde initiates a domino sequence involving intermolecular addition
followed by an intramolecular silyl-modified Sakurai (ISMS) reaction. Isolated yields of this one-pot re-
action vary from 44 to 80% and all compounds were isolated as the cis-diastereomers (10 examples).
 2009 Elsevier Ltd. All rights reserved.
1. Introduction
In efforts to reduce environmental impacts, increase atom
economy as well as overall efficiency and convergence of experi-
mental protocols, one-pot, multi-component reactions (MCRs)1
have become increasingly common in organic synthesis. Efforts
toward a number of natural products have resulted in the de-
velopment of several protocols in which formation of an initial
adduct is required to provide the substrate for a subsequent
reaction. The literature has alternatively referred to such processes
as tandem, multi-component, cascade, or domino reactions, al-
though the precise meaning of each adjective has not been entirely
consistent.2
As part of a program to further develop the uses of environ-
mentally-benign3,4 Bi(III) compounds in organic synthesis, we re-
cently described5 the BiBr3-initiated intermolecular addition
followed by intramolecular silyl-modified Sakurai reaction (ISMS) 6,7
toward 2,6-disubstituted dihydropyrans (DHPs) with cis-diaster-
eoselectivity (Eq. 1). Similar DHPs were either present in, or could
be used as intermediates toward syntheses of a number of
biologically active natural products such as ambruticin 1,8 the
phorboxazoles,9 leucascandrolide10, kendomycin,11 neopeltolide,12
the clavisolides,13 and the diospongins.14 The prevalence of DHPs,
and derivatives thereof, has led to a large number of concise and
selective methods for their synthesis.15–18
More specifically, the utility of a DHP moiety attached to the
a-position of a carbonyl compound19 prompted us to further in-
vestigate a three-component, one-pot cascade reaction involving an
initial Mukaiyama aldol reaction followed by an addition/ISMS se-
quence as shown in the retrosynthetic analysis below (Scheme 1).
Given how rapidly molecular complexity is increased in this short
sequence, we examined the utility of several silane nucleophiles, 1,
and aldehydes (R0CHO). Herein, we report further examples of this
multi-component, one pot reaction and details of our optimization
studies.
2. Results and discussion
In order to evaluate the feasibility of the first step of the three-
component process,weprepared aldehyde, (Z)-2, in two, straightforward
steps from commercially-available 4-trimethylsilyl-3-butyn-1-ol.20
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Scheme 1. Retrosynthetic analysis of 2,6-disubstituted DHPs.
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Reduction under nickel catalyzed conditions (P-2)16k was most
convenient as it led to the best (Z):(E) ratios (>95:5) with little or no
over-reduction to the alkane. As expected, the resulting b,g-un-
saturated aldehyde, 2,5 is particularly sensitive, and Dess–Martin
periodinane21 was the only oxidant that afforded the desired sub-
strate in sufficient purity to study the three-component sequence.
We chose to focus on using the (Z)-vinylsilane due to recent work
by Meilert and Brimble22 as well Dobbs et al.23 showing that the
cis-vinylsilane isomers efficiently participated in intramolecular
reactions.
The initial Mukaiyama aldol24–26 between 2 and the commer-
cially-available methyl trimethylsilyldimethyl-ketene acetal (1;
R¼OMe, R1¼H) readily occurred at room temperature (Scheme 2) in
the presence of 10 mol % BiBr3 in CH2Cl2 (w0.1 M). Crude
1H NMR
spectroscopic analyses and TLC indicated that the initialMukaiyama
aldol reaction cleanly affords the sensitive silylated aldol adduct, A,
which is an effective nucleophile for the second addition/silyl-Prins
step (ISMS).5 Although the free alcohol corresponding to A could be
isolated by column chromatography, in practice, we carried A onto
the next step without isolation or purification. Mukaiyama aldol
reactions involving Bi(III) are also efficient in CH3CN, but we chose
CH2Cl2 as the solvent since our previous studies indicated that the
intermolecular addition and ISMS occurred more efficiently in this
solvent versus CH3CN.
5 Addition of a second aldehyde (R2CHO) and
10 mol %more BiBr3 results in an intermolecular addition ofA to the
second aldehyde (R2CHO) to afford the E-oxocarbenium ion, B. An
intramolecular silyl-Prins reaction then affords 3a–3j via the in-
termediate stabilized cation, C.
When using 1.1–1.4 equiv of ketene acetal (Table 1, entries 1–4
and 11), the initial aldol reaction occurs very rapidly at tempera-
tures down to 20 C in CH2Cl2 or CH3CN. During optimization, we
did find that the single most important variable for clean formation
of the Mukaiyama adduct, A, was the specific commercial samples
of ketene silyl acetal. Although we examined individual samples by
1H and 13C NMR spectroscopy and found no significant impurities,
some reactions required up to 1.4 equiv of the ketene silyl acetal
nucleophile whereas another was effectively used with as little as
1.1 equivalents. This is most likely due to variations in trace water
content and competing hydrolysis reactions during the Mukaiyama
aldol step.
In all cases in which silyl enol ethers were used instead of the
more nucleophilic ketene silyl acetals27 at the same concentration
(entry 3 vs 5), the reaction was much slower at room temperature
and did not proceed to completion unless the BiBr3 was activated
by sonication in the presence of NaI as reported by Le Roux et al.28
This presumably affords the more reactive BiI3 salt in situ. We later
found, however, that activation and sonication could be avoided,
albeit less efficiently, if the aldol was conducted atw0.2 M instead
ofw0.1 M without NaI activation (entries 6 vs 7 and 8 vs 9).
In all cases where the hydrogens adjacent to the oxygen in the
ring system could be sufficiently separated in the 1H NMR spec-
trum, qualitative 1H NOE spectra indicated that the cis-isomers29 of
DHPs 3a–j were the only diastereomers observed in agreement
with other silyl-Prins type cyclizations (Fig. 1).22,23
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Scheme 2. Reaction sequence for the three-component, one-pot synthesis of
dihydropyrans.
Table 1
Three-component, one-pot reaction to 2,6-disubstituted dihydropyrans
R
OTMS
+ + R2CHOR1
R1
O R2
O
R
R1R1
BiBr3
CH2Cl2
1
O
TMS
H
3a-j2
Entry R R1 R2 Product dr (cis:trans)a Yieldb (%)
1 MeO– –Me PhCH2– 3a >99:1 64
2 MeO– –Me i-Pr– 3b >99:1 53
3 MeO– –Me n-C5H11– 3c >99:1 64
4 MeO– –Me ortho-CHOC6H4– 3d >99:1 55
5 Ph– –H n-C5H11– 3e >99:1 76
c
6 Ph– –H 1-ethylpropyl– 3f >19:1 66c
7 Ph– –H 1-ethylpropyl– 3f >19:1 56d
8 tert-Bu– –H n-C7H15– 3g >19:1 80
c
9 tert-Bu– –H n-C7H15– 3g >19:1 55
d
10 tert-Bu– –H PhCH2CH2– 3h >19:1 52
d
11 MeO– –Me PhCH2CH2– 3i >19:1 63
12 Ph– –H Ph– 3j >19:1 44d
a Diastereoselectivities were determined by 1H NMR or GC–MS analysis of crude reaction mixtures prior to chromatographic separation.
b Yields are reported for pure, isolated cis-compounds characterized by 1H NMR and 13C NMR spectroscopy, IR spectrometry and HRMS or elemental analysis.
c Initial Mukaiyama aldol carried out at w0.1 M with added NaI and sonication.
d Initial Mukaiyama aldol carried out at w0.2 M with neither added NaI, nor sonication.
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Figure 1. Observed qualitative NOE enhancement.
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We were particularly interested in syntheses using b,b-unsub-
stituted enol ethers as nucleophiles since these resulting in-
termediates and products might be prone to aldol reactions or
eliminations via putative enols or enolates. We were gratified to
isolate several products with enolizable hydrogens a- to the car-
bonyl moiety; these were obtained in yields ranging from 52% to
80% (entries 5–10). The lowest yield was observed for product 3j
(entry 12) even though both the initial Mukaiyama aldol and the
subsequent addition/silyl-Prins reactions appeared clean by TLC
analysis and 1H NMR spectroscopic evaluation of the crude product.
This particular product appeared less stable than the other nine and
prolonged reaction times led to complex mixtures while storage at
room temperature also caused decomposition. This instability is
likely due to the fact that the phenyl substituent (R2) promotes ring
opening under the reaction conditions via a benzylic cation.
Although we attempted cyclizations using (E)-vinylsilanes due
to reports that the (E)-vinylsilanes provided trans-2,6-diaster-
eomers,16k we found that in the two-component case analogous to
that in Eq. 1, only trace quantities of cyclization products were
afforded (GC–MS) using (E)-vinylsilanols.5 This result is consistent
with the stereoelectronic stabilization of the developing cation by
the axial trimethylsilyl moiety in intermediates B and C (Scheme 2)
as described by Speckamp16k and Roush16i for DHPs as well as
Overman30 and Tanner31 for iminium ion cyclizations.
The exact role(s) of Bi(III) compounds as catalysts in organic syn-
thesis is still debated in numerous papers. Whereas BiX3 compounds
are often described as weak Lewis acids,3,32,33 and investigators have
attributed their reactivity to this property, we34 and others35 believe
that BiX3 species are progenitors of Brønsted acids and that these
contribute to the activities of BiX3 salts. Even in caseswhere Brønsted
acids have been shown to be involved, their specific role is not always
clear,36,37,38 especially in the presence of Lewis acids.39
Bismuth(III) halides are known to rapidly hydrolyze to H–X and
bismuthoxy halides (X–Bi]O) which are insoluble in CH2Cl2.
40 In
the cases of silyl enol ethers (Table 1, entries 5–10 and 12), the
solutions become homogeneous after addition of the second al-
dehyde (R2CHO), so insoluble Br–Bi]O does not accumulate. In
addition, ligand exchange reactions involving the kinetically-labile
Bi(III) center can produce reactive intermediates in acylation and
other reactions.36,37,38 Finally, Mukaiyama aldol reactions occur
with addition of 100 mol % methyl di-tert-butylpyridine (DTBP) in
the presence of 15 mol % of BiBr3. Regardless of the explicit and
potentially complex role(s) of BiBr3, use of this salt in catalytic
quantities is convenient and inexpensive.
In short, we have developed an efficient, diastereoselective one-
pot, three component Mukaiyama aldol/addition/ISMS reaction to
afford valuable 2,6-disubsituted dihydropyran products. Both
ketene silyl acetals and silyl enol ethers are effective nucleophiles
with b,g-unsaturated aldehyde, 1. Aliphatic, benzylic and aromatic
aldehydes were all useful as the second electrophile (R2CHO), al-
though benzaldehyde provided the lowest yield. We are in the
process of further optimizing reactions with aromatic aldehydes,
establishing the role(s) of BiBr3 in the reaction sequence as well as
applying this methodology toward more substituted products.
3. Experimental section
3.1. General
All reagents were used as received unless otherwise noted.
Dichloromethane was distilled from CaH2 and THF was purified via
a Solv-Tek solvent purification system. Benzaldehyde, phthalde-
hyde, isobutyraldehyde as well as 2-ethylbutyraldehyde were pur-
chased from Acros Organics. Dess-Martin periodininane, hexanal,
octanal, bismuth bromide, methyl trimethylsilyl dimethylketene
acetal, (2,2-dimethyl-1-methylenepropoxy)trimethylsilane, and
1-phenyl-1-trimethylsiloxyethylene were purchased from Aldrich
Chemical Company. 4-Trimethylsilyl-3-butyn-1-ol was purchased
from GFS Chemical. 13C NMR spectra were recorded with the aid of
an APTsequence inwhichmethylene and quaternary carbons¼even
(e) and methyl and methine carbons¼odd (o). Coupling constants
were determined by the method of Hoye.41 Thin layer chromatog-
raphy was performed on Sorbent Technologies general-purpose
silica gel on glass and flash chromatography was performed using
Sorbent Technologies chromatographic silica gel (200–475 MESH).
All compoundswere judged to be homogeneous by 1H and 13C NMR
spectroscopy.
3.2. General procedure
3.2.1. Preparation of methyl cis-2-(6-benzyl-3,6-dihydro-2H-
pyran-2-yl)-2,2–dimethyl propanoate (3a)
BiBr3 (45 mg, 0.10 mmol, 0.10 equiv) was weighed into 25 mL
round bottom flask and 10 mL CH2Cl2 was added via syringe. (Z)-4-
(trimethylsilyl)but-3-enal, 25 (0.142 g, 1.00 mmol, 1.00 equiv) and
methyl trimethylsilyl dimethylketene acetal (0.192 g, 1.10 mmol,
1.10 equiv) were added by syringe simultaneously. The mixture was
stirred at room temperature until (Z)-4-(trimethylsilyl)but-3-enal,
2was consumed by TLC (3 h). Additional BiBr3 (45 mg, 0.010 mmol,
0.10 equiv) and phenylacetaldehyde (0.24 g, 2.0 mmol, 2.0 equiv)
were added and the mixture was stirred for 12 h at rt. The solution
was concentrated in vacuo, filtered through a small SiO2 pipette
columnwith CH2Cl2 as eluent and concentrated in vacuo again. The
product was purified by column chromatography (9:1 petroleum
ether:Et2O, Rf¼0.34) to provide 0.175 g (64%) of cis-isomer as
a colorless oil: IR (neat) 3031 (s), 2982 (s), 2940 (s), 2879 (m), 1735
(s), 1451 (m), 1267 (s), 1140 (s), 1086 (s), 751 (m); 1H NMR
(400 MHz, CDCl3) d 7.17–7.28 (m, 5H), 5.77–5.82 (m, 1H), 5.63 (dm,
J¼10.3 Hz, 1H), 4.27 (br, 1H), 3.77 (dd, J¼11.0, 3.3 Hz, 1H), 3.55 (s,
3H), 2.83 (dd, J¼13.9, 8.1 Hz, 1H), 2.70 (dd, J¼13.9, 8.1 Hz,1H), 2.06–
2.15 (m, 1H), 1.77–1.85 (m, 1H), 1.21 (s, 3H), 1.20 (s, 3H); 13C NMR
(APT) (100 MHz, CDCl3) d 177.2 (e), 138.7 (e), 129.72 (o), 129.69 (o),
128.0 (o),126.1 (o), 125.0 (o), 78.4 (o), 76.5 (o), 52.0 (o), 46.6 (e), 42.1
(e), 25.4 (e), 21.3 (o), 20.4 (o). Anal. Calcd for C17H22O3 (274.35): C
74.42, H 8.08; found: C 74.53, H 8.30.
3.2.2. Preparation of methyl cis-2-(6-isopropyl-3,6-dihydro-2H-
pyran-2-yl)-2,2–dimethyl propanoate (3b)
Using the general procedure, 3b was prepared from BiBr3
(45 mg, 0.10 mmol, 0.10 equiv), (Z)-4-(trimethylsilyl)but-3-enal 2
(0.142 g, 1.00 mmol, 1.00 equiv), methyl trimethylsilyl dimethylke-
tene acetal (0.192 g, 1.10 mmol, 1.10 equiv), isobutyraldehyde
(0.182 mL, 2.00 mmol, 2.00 equiv), and BiBr3 (45 mg, 0.10 mmol,
0.10 equiv). The product was purified by column chromatography
(9:1 petroleum ether:Et2O, Rf¼0.52) to provide 0.120 g (53%) of cis-
isomer as a colorless oil: IR (neat) 2961 (s), 1737 (s), 1458 (w), 1368
(w), 1258 (m), 1136 (m), 1084 (m); 1H NMR (400 MHz, CDCl3)
d 5.80–5.85 (m,1H), 5.63 (dm, J¼10.3 Hz,1H), 3.86 (br,1H), 3.75 (dd,
J¼10.6, 2.9 Hz, 1H), 3.67 (s, 3H), 2.04–2.12 (m, 1H), 1.76–1.83 (m,
1H), 1.70 (dtt, J¼7.0, 7.0, 5.1 Hz, 1H), 1.22 (s, 3H), 1.14 (s, 3H), 0.90 (d,
J¼7.0 Hz, 3H), 0.86 (d, J¼7.0 Hz, 3H); 13C NMR (APT) (100 MHz,
CDCl3) d 177.4 (e), 128.9 (o), 125.1 (o), 80.0 (o), 77.9 (o). 52.0 (o), 46.7
(e), 32.9 (o), 25.5 (e), 21.2 (o), 20.4 (o), 18.6 (o), 17.5 (o). Anal. Calcd
for C13H22O3 (226.31): C 68.99, H 9.80; found: C 68.29, H 9.61.
3.2.3. Preparation of methyl cis-2-(6-pentyl-3,6-dihydro-2H-
pyran-2-yl)-2,2-dimethyl propanoate (3c)
This compound was prepared according to the general pro-
cedure described for 3a using BiBr3 (45 mg, 0.10 mmol, 0.10 equiv),
(Z)-4-(trimethylsilyl)but-3-enal, 2 (0.142 g, 1.00 mmol, 1.00 equiv),
methyl trimethylsilyl dimethylketene acetal (0.192 g, 1.10 mmol,
1.10 equiv), hexanal (0.14 mL, 2.0 mmol, 2.0 equiv) and BiBr3
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(45 mg, 0.10 mmol, 0.10 equiv). The product was purified by column
chromatography (9:1 petroleum ether:Et2O, Rf¼0.52) to provide
0.163 g (64%) of cis-isomer as a colorless oil: IR (neat) 3032 (m),
2953 (s), 2934 (s), 2861 (s), 1737 (s), 1469 (m), 1368 (w), 1265 (s),
1190 (m),1134 (m),1083 (m); 1H NMR (400 MHz, CDCl3) d 5.74–5.80
(m, 1H), 5.59 (dm, J¼10.3 Hz, 1H), 4.05 (br, 1H), 3.76 (dd, J¼10.9,
2.3 Hz, 1H), 3.67 (s, 3H), 2.05–2.14 (m, 1H), 1.76–1.84 (m, 1H), 1.23–
1.48 (m, 8H), 1.22 (s, 3H), 1.13 (s, 3H), 0.88 (t, J¼7.0 Hz, 3H); 13C NMR
(APT) (100 MHz, CDCl3) d 177.4 (e), 130.8 (o), 124.3 (o), 78.2 (o), 75.5
(o), 52.0 (o), 46.6 (e), 35.5 (e), 32.0 (e), 25.5 (e), 25.1 (e), 23.0 (e), 21.1
(o), 20.5 (o), 14.4 (o). Anal. Calcd for C15H26O3 (254.37): C 70.83, H
10.30; found: C 70.63, H 10.27.
3.2.4. Preparation of methyl cis-2-(6-(2-formylphenyl)-3,6-
dihydro-2H-pyran-2-yl)-2,2-dimethyl-propanoate (3d)
This compound was prepared according to the general
procedure using BiBr3 (22 mg, 0.05mmol, 0.10 equiv), (Z)-4-
(trimethylsilyl)but-3-enal, 2 (0.071 g, 0.50 mmol, 1.00 equiv), methyl
trimethylsilyl dimethylketene acetal (0.096 g, 0.55 mmol,1.10 equiv),
phthalaldehyde (0.134 g, 1.00 mmol, 2.00 equiv), and additional
BiBr3 (22 mg, 0.05 mmol, 0.10 equiv). The product was purified by
column chromatography (8:2 petroleum ether:Et2O, Rf¼0.22) to
provide 0.079 g (55%) of cis-isomer as a colorless oil: IR (neat) 3743
(w), 2980 (w), 1733 (s), 1698 (s), 1558 (m), 1464 (m), 1266 (m), 1195
(m), 1139 (m), 1077 (m), 760 (m); 1H NMR (400 MHz, CDCl3) d 10.33
(s, 1H), 7.88 (dd, J¼7.7, 1.1 Hz, 1H), 7.56–7.63 (m, 2H), 7.47 (td, J¼7.3,
1.5 Hz, 1H), 5.90–5.95 (m, 1H), 5.85–5.88 (m, 1H), 5.78–5.82 (dm,
J¼10.3 Hz, 1H), 4.13 (dd, J¼11.0, 3.3 Hz, 1H), 3.70 (s, 3H), 2.27–2.38
(m, 1H), 1.97–2.04 (dm, J¼17.2 Hz, 1H), 1.29 (s, 3H), 1.22 (s, 3H);
13C NMR (APT) (100 MHz, CDCl3) d 192.7 (o), 177.0 (e), 143.6 (e),
134.0 (o), 133.6 (e), 131.4 (o), 129.7 (o), 128.0 (o), 127.8 (o), 124.7
(o), 78.8 (o), 75.5 (o), 52.2 (o), 46.7 (e), 25.1 (e), 21.4 (o), 20.6 (o);
HRMS (ESI) calcd for C17H20O4Na (MþNaþ) 311.1254, found
311.1251.
3.2.5. Preparation of cis-2-(6-pentyl-3,6-dihydro-2H-pyran-2-yl)-
1-phenylethanone (3e)
BiBr3 (22 mg, 0.05 mmol, 0.10 equiv) and NaI (23 mg, 0.15 mmol,
0.30 equiv) were weighed into 15 mL round bottom flask and 10 mL
CH2Cl2 was added via syringe. After sonicating for 1 h at rt, (Z)-4-
(trimethylsilyl)but-3-enal, 2 (0.071 g, 0.50 mmol, 1.00 equiv) and 1-
phenyl-1-trimethylsilyloxyethylene (0.106 g, 0.55 mmol, 1.10 equiv)
were added by syringe simultaneously. Themixturewas stirred until
(Z)-4-(trimethylsilyl)but-3-enal, 2, was consumed by TLC analysis
(2 h). Hexanal (0.134 g, 1.00 mmol, 2.00 equiv) and additional BiBr3
(22 mg, 0.05 mmol, 0.10 equiv) were added and the mixture was
stirred for 12 h. The solution was concentrated in vacuo, filtered
through a small SiO2 pipette column with CH2Cl2 as eluent and
concentrated in vacuo again. The product was purified by column
chromatography (9:1 petroleum ether:Et2O, Rf¼0.38) to provide
0.104 g (76%) of cis-isomer as a colorless oil: IR (neat) 3743 (w), 2929
(s), 2861 (s), 1686 (s), 1452 (m), 1371 (m), 1336 (m), 1281 (m), 1217
(m),1181 (m),1075 (m), 993 (m), 751 (m); 1HNMR (400 MHz, CDCl3)
d 7.98–8.01 (m, 2H), 7.56 (tt, J¼7.3, 1.5 Hz, 1H), 7.44–7.48 (m, 2H),
5.77–5.82 (m,1H), 5.64 (dm, J¼10.3 Hz,1H), 4.16–4.23 (m,1H), 4.08–
4.14 (m,1H), 3.40 (dd, J¼15.7, 6.6 Hz,1H), 2.98 (dd, J¼15.7, 6.6 Hz,1H),
2.02–2.18 (m, 2H), 1.18–1.50 (m, 8H), 0.85 (t, J¼6.7 Hz, 3H); 13C NMR
(APT) (100 MHz, CDCl3) d 198.5 (e),137.5 (e),133.1 (o),130.6 (o),128.6
(o), 128.4 (o), 124.2 (o), 75.2 (o), 71.0 (o), 45.4 (e), 35.8 (e), 32.1 (e),
31.6 (e), 25.1 (e), 22.9 (e),14.4 (o). Anal. Calcd for C18H24O2 (272.38): C
79.37, H 8.88; found: C 79.22, H 9.01.
3.2.6. Preparation of cis-2-(6-(pentan-3-yl)-3,6-dihydro-2H-
pyran-2-yl)-1-phenylethanone (3f)
BiBr3 (45 mg, 0.10 mmol, 0.10 equiv) and NaI (50 mg,
0.15 mmol, 0.30 equiv) were weighed into 15 mL round bottom
flask and 5 mL CH2Cl2 was added via syringe. After sonicating for
1 h at rt, (Z)-4-(trimethylsilyl)but-3-enal, 2 (0.142 g, 1.00 mmol,
1.00 equiv) and 1-phenyl-1-trimethylsiloxyethylene (0.212 g,
1.10 mmol, 1.10 equiv) were added by syringe simultaneously.
The mixture was stirred until (Z)-4-(trimethylsilyl)but-3-enal, 2,
was consumed (2 h). 2-Ethylbutyraldehyde (0.182 mL, 1.47 mmol,
1.47 equiv) and BiBr3 (45 mg, 0.10 mmol, 0.10 equiv) were added
and the mixture was stirred for 12 h. The solution was concen-
trated in vacuo, filtered through a small SiO2 pipette column
with CH2Cl2 as eluent and concentrated in vacuo again. The
product was purified by column chromatography (9:1 petroleum
ether:Et2O, Rf¼0.40) to provide 0.179 g (66%) of cis-isomer as
a light yellow oil: IR (neat) 3032 (m), 2961 (s), 2932 (s), 2874 (s),
1684 (s), 1449 (m), 1279 (m), 1214 (m), 1184 (m), 1072 (s), 992
(m), 752 (m); 1H NMR (400 MHz, CDCl3) d 7.98–8.01 (dm,
J¼8.3 Hz, 2H), 7.56 (app. tm, J¼7.3 Hz, 1H), 7.44–7.48 (m, 2H),
5.81–5.86 (m, 1H), 5.63 (dm, J¼10.3 Hz, 1H), 4.12–4.19 (m, 2H),
3.36 (dd, J¼15.7, 6.6 Hz, 1H), 2.94 (dd, J¼15.7, 6.6 Hz, 1H), 2.01–
2.16 (m, 2H), 1.16–1.40 (m, 5H), 0.84 (t, J¼7.0 Hz, 3H), 0.83 (t,
J¼7.0 Hz, 3H); 13C NMR (APT) (100 MHz, CDCl3) d 198.9 (e), 137.6
(e), 133.0 (o), 129.4 (o), 128.6 (o), 128.5 (o), 124.8 (o), 76.6 (o),
71.2 (o), 46.0 (o), 45.5 (e), 31.7 (e), 22.5 (e), 22.2 (e), 12.38 (o),
12.36 (o). Anal. Calcd for C18H24O2 (272.38): C 79.37, H 8.88;
found: C 79.71, H 8.96.
3.2.7. Preparation of cis-1-(6-heptyl-3,6-dihydro-2H-pyran-2-yl)-
3,3-dimethylbutan-2-one (3g)
BiBr3 (45 mg, 0.10 mmol, 0.10 equiv) and NaI (50 mg, 0.15 mmol,
0.30 equiv) were weighed into 15 mL round bottom flask and 5 mL
CH2Cl2 was added via syringe. After sonicating for 1 h at rt, (Z)-4-
(trimethylsilyl)but-3-enal, 2 (0.142 g, 1.00 mmol, 1.00 equiv) and
(2,2-dimethyl-1-methylenepropoxy)trimethylsilane (0.190 g, 1.10
mmol, 1.10 equiv) were added by syringe simultaneously. The mix-
ture was stirred until (Z)-4-(trimethylsilyl)but-3-enal, 2 was con-
sumed (2 h). Octanal (0.313 mL, 2.00 mmol, 2.00 equiv) and BiBr3
(45 mg, 0.10 mmol, 0.10 equiv) were added and the mixture was
stirred for 24 h. The solution was concentrated in vacuo, filtered
through a small SiO2 pipette column with CH2Cl2 as eluent and
concentrated in vacuo again. The product was purified by column
chromatography (9:1 petroleum ether:Et2O, Rf¼0.43) to provide
0.225 g (80%) of cis-isomer as a colorless oil: IR (neat) 3032 (m), 2957
(s), 2929 (s), 2858 (s),1708 (s),1465 (m),1367 (m),1185 (m),1076 (s),
994 (m), 840 (w); 1H NMR (400 MHz, CDCl3) d 5.63–5.68 (m, 1H),
5.51 (dm, J¼10.3 Hz, 1H), 3.93–4.05 (m, 2H), 2.81 (dd, J¼16.8, 7.0 Hz,
1H), 2.36 (dd, J¼16.8, 7.0 Hz, 1H), 1.79–1.97 (m, 2H), 1.10–1.40 (m,
12H), 1.04 (s, 9H), 0.77 (t, J¼6.7 Hz, 3H); 13C NMR (APT) (100 MHz,
CDCl3) d 213.8 (e), 130.6 (o), 124.2 (o), 75.2 (o), 70.7 (o), 44.6 (e), 43.3
(e), 35.9 (e), 32.1 (e), 31.3 (e), 29.9 (e), 29.6 (e), 26.4 (o), 25.5 (e), 23.0
(e), 14.5 (o). Anal. Calcd for C18H32O2 (280.45): C 77.09, H 11.50;
found: C 76.81, H 11.31.
3.2.8. Preparation of cis-3,3-dimethyl-1-(6-phenethyl-3,6-dihydro-
2H-pyran-2-yl)butan-2-one (3h)
BiBr3 (48 mg, 0.11 mmol, 0.10 equiv) was weighed into 15 mL
round bottom flask and 5.0 mL CH2Cl2 was added via syringe. After
stirring the BiBr3 suspension for 5 min, (Z)-4-(trimethylsilyl)but-3-
enal, 2 (0.152 g, 1.07 mmol, 1.00 equiv) and (2,2-dimethyl-1-methyl-
enepropoxy)trimethylsilane (0.206 g, 1.17 mmol, 1.09 equiv) were
separately dissolved in 0.25 mL CH2Cl2 and added by syringe
simultaneously. The mixture was stirred until (Z)-4-(trimethylsi-
lyl)but-3-enal, 2was consumed by TLC analysis (2 h). BiBr3 (51 mg,
0.11 mmol, 0.10 equiv) and 3-phenylpropanal (0.281 mL,
2.14 mmol, 2.00 equiv) and were then added and the mixture was
stirred for 14 h. The solution was concentrated in vacuo, filtered
through a small SiO2 column with CH2Cl2 as eluent and concen-
trated in vacuo again. The product was purified by column
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chromatography (95:5 to 9:1 petroleum ether:Et2O, Rf¼0.50 in 9:1
hexanes:EtOAc) to provide 0.158 g (52%) of the cis-isomer as a col-
orless oil: IR (neat) 3062 (m), 3027 (s), 2967 (vs), 2933 (m), 2869 (s),
1705 (vs), 1087 (vs), 1068 (vs); 1H NMR (400 MHz, CDCl3) d 7.26–
7.32 (m, 2H), 7.16–7.21 (m, 3H), 5.81 (dddd, J¼9.9, 7.3, 4.8, 2.2 Hz,
1H), 5.62 (dddd, J¼10.3, 4.0, 2.7, 1.5 Hz, 1H), 4.09–4.15 (m, 2H),
2.97(dd, J¼16.5, 7.3 Hz, 1H), 2.62–2.79 (m, 2H), 2.47 (dd, J¼16.5,
5.1 Hz, 1H), 1.94–2.10 (m, 2H), 1.74–1.82 (m, 2H), 1.19 (s, 9H); 13C
(APT) (100 MHz, CDCl3) d 213.6 (e), 142.3 (e), 130.3 (o), 128.6 (o),
128.4 (o), 125.8 (o), 124.6 (o), 74.1 (o), 70.7 (o), 44.6 (e), 43.2 (e), 37.6
(e), 31.7 (e), 31.3 (e), 26.4 (o). Anal. Calcd for C19H26O2 (286.41): C
79.68, H 9.15; found: C 79.64, H 9.18.
3.2.9. Preparation of methyl 2-methyl-2-(6-phenethyl-3,6-dihydro-
2H-pyran-2-yl)propanoate (3i)
BiBr3 (58 mg, 0.13 mmol, 0.10 equiv) was weighed into 15 mL
round bottom flask and 5.0 mL CH2Cl2 was added via syringe. After
stirring the BiBr3 suspension for 5 min, (Z)-4-(trimethylsilyl)but-3-
enal, 2 (0.180 g, 1.27 mmol, 1.00 equiv) and methyl trimethylsilyl
dimethylketene acetal (0.295 g,1.69mmol,1.33 equiv) were separately
dissolved in 0.25 mL CH2Cl2 and added by syringe simultaneously.
The mixture was stirred until (Z)-4-(trimethylsilyl)but-3-enal, 2
was consumed by TLC analysis (1.5 h). BiBr3 (58 mg, 0.13 mmol,
0.10 equiv) was then added followed by 3-phenylpropanal
(0.340 mL, 2.52 mmol, 1.98 equiv) and the mixture was stirred for
14 h. The solution was concentrated in vacuo, filtered through
a small SiO2 pipette column with CH2Cl2 as eluent and concen-
trated in vacuo again. The product was finally purified by column
chromatography (95:5 to 9:1 petroleum ether:Et2O, Rf¼0.48 in 9:1
hexanes:EtOAc) to provide 0.237 g (65%) of the cis-isomer as
a colorless oil: IR (neat) 3028 (vs), 2980 (vs), 2874 (vs), 1728 (vs);
1H NMR (400 MHz, CDCl3) d 7.24–7.29 (m, 2H), 7.14–7.20 (m, 3H)
5.80 (dddd, J¼9.9, 4.2, 2.0, 2.0 Hz, 1H), 5.58 (dddd, J¼9.9, 2.9, 1.5,
1.5 Hz, 1H), 4.08 (br s, 1H), 3.80 (dd, J¼10.8, 3.1 Hz, 1H), 3.70 (s,
3H), 2.62–2.80 (m, 2H), 2.08–2.17 (m, 1H), 1.68–1.74 (m, 3H), 1.26
(s, 3H), 1.16 (s, 3H); 13C (APT) (100 MHz, CDCl3) d 177.3 (e), 142.5
(e), 130.4 (o), 128.7 (o), 128.3 (o), 125.7 (o), 124.7 (o), 78.1 (o), 74.3
(o), 52.0 (o), 46.6 (e), 37.4 (e), 31.5 (e), 25.5 (e), 21.2 (o), 20.5 (o);
Anal. Calcd for C18H24O3 (286.41): C 74.97, H 8.39; found: C 74.92,
H 8.44.
3.2.10. Preparation of 2-(6-phenyl-3,6-dihydro-2H-pyran-2-yl)-1-
phenylethanone (3j)
BiBr3 (48 mg, 0.11 mmol, 0.10 equiv) was weighed into 15 mL
round bottom flask and 3.5 mL CH2Cl2 was added via syringe. After
stirring the BiBr3 suspension for 5 min, (Z)-4-(trimethylsilyl)but-3-
enal, 2 (0.153 g, 1.07 mmol, 1.00 equiv) and 1-phenyl-1-trimethyl-
siloxyethylene (0.237 g, 1.23 mmol, 1.15 equiv) were dissolved
separately in 0.25 mL CH2Cl2 and added by syringe simultaneously.
The mixture was stirred until (Z)-4-(trimethylsilyl)but-3-enal, 2
was consumed by TLC analysis (1.5 h). BiBr3 (50 mg, 0.11 mmol,
0.10 equiv) and benzaldehyde (0.218 mL, 2.15 mmol, 2.01 equiv)
were then added and the mixture was stirred for 4 h. The solution
was concentrated in vacuo, filtered through a small SiO2 pipette
columnwith CH2Cl2 as eluent and concentrated in vacuo again. The
product was finally purified by column chromatography (95:5 to
9:1 petroleum ether:Et2O, Rf¼0.16 with 9:1 petroleum ether:Et2O)
to provide 0.131 g (44%) of the cis-isomer as a light yellow oil: IR
(film) 3062 (m), 3033 (m), 2922 (m), 1683 (vs), 1598 (vs), 1450 (vs);
1H NMR (400 MHz, CDCl3) d 7.97 (dm, J¼8.1 Hz, 2H), 7.52–7.58 (m,
1H), 7.42–7.48 (m, 2H), 7.32–7.38 (m, 4H), 7.24–7.30 (m, 1H), 5.91–
5.97 (m, 1H), 5.77 (dm, J¼10.3 Hz, 1H), 5.24 (br s, 1H), 4.46 (dddd,
J¼9.9, 6.2, 4.0, 4.0 Hz, 1H), 3.47 (dd, J¼16.5, 6.2 Hz, 1H), 3.10 (ddd,
J¼16.5, 6.2, 0.7 Hz, 1H), 2.15–2.33 (m, 2H); 13C (APT) (100 MHz,
CDCl3) d 198.0 (e), 141.4 (e), 137.3 (e), 133.2 (o), 130.0 (o), 128.7 (o),
128.6 (o), 128.4 (o), 127.9 (o), 127.3 (o), 124.6 (o), 77.9 (o), 71.0 (o),
45.3 (e), 31.1 (e); HRMS (ESI) calcd for C19H18O2Na (MþNaþ)
301.1199, found 301.1195.
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